| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -38.2% |
| R&D Expense | $81.4M | +27.5% |
| SG&A Expense | $35.1M | -3.1% |
| Operating Income | -$120.3M | -10.5% |
| Pre-tax Income | -$115.1M | -11.7% |
| Income Tax | $69K | -1.4% |
| Net Income | -$115.2M | -11.7% |
| EPS (Basic) | -$0.84 | +10.6% |
| EPS (Diluted) | -$0.84 | +10.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -51.4% |
| Short-term Investments | $124.3M | +74.5% |
| Current Assets | $149.6M | +11.8% |
| Total Assets | $216.3M | +1.3% |
| Current Liabilities | $22.8M | -20.6% |
| Total Liabilities | $26.8M | -22.1% |
| Stockholders' Equity | $189.4M | +5.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.9M | -28.3% |
| Capital Expenditures | $1.1M | +174.0% |
| Investing Cash Flow | -$50.2M | -20.6% |
| Financing Cash Flow | $105.9M | +28.4% |
| Free Cash Flow | -$94.0M | -29.2% |